Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹6,376 Cr₹5,967 Cr₹5,819 Cr₹4,546 Cr₹4,689 Cr

What is the latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹6,376 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹6,376 Cr
Mar2025₹5,967 Cr
Mar2024₹5,819 Cr
Mar2023₹4,546 Cr
Mar2022₹4,689 Cr

How is Total Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Current Liabilities % Change
Mar2026 ₹6,376 Cr
6.86
Mar2025 ₹5,967 Cr
2.55
Mar2024 ₹5,819 Cr
27.99
Mar2023 ₹4,546 Cr
-3.05
Mar2022 ₹4,689 Cr -

Compare Total Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹71,041.0 Cr 5.5% 14.9% 26.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

5.5%

14.9%

26.8%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses